Mergers and Growth Element’s acquisition-driven growth and integration with VR Analytical suggests expanded capacity and service breadth. This presents cross-sell opportunities for E/L testing, regulatory consulting, and end-to-end product development support across larger enterprise accounts.

Regulatory Expertise The combined entity emphasizes regulatory interpretation and quality-focused extractables and leachables services. Target prospects in biopharma manufacturing seeking compliant and efficient E/L studies can benefit from strategic partnerships and expanded SOP alignment.

Global Scale Element’s global platform and investments, including new facilities, indicate capacity to support multinational programs. Offer scalable E/L testing and global regulatory strategy to sponsors with cross-border manufacturing and complex supply chains.

Aerospace and Defense Synergy Recent facility expansions aimed at aerospace and defense materials testing imply broader materials science capabilities. Use this to position cross-industry E/L expertise for complex packaging or material compatibility projects in pharma supply chains with high-stakes materials exposure.

Technology Enablement Existing tech stack (SAS, GitHub, Sitecore, Hyperion, New Relic, etc.) supports advanced analytics, data management, and regulatory reporting. Propose enhanced data-driven E/L studies, dashboards, and automated regulatory documentation to accelerate time-to-market for clients.